Middle East & Africa Colorectal Cancer Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality (Diagnosis Type, Therapy Type, and Imaging Type) and End User (Hospitals and Diagnostic & Research Laboratories) 

Code: BMIRE00026182 | Pages: 162 | Industry: Pharmaceuticals | Date: Sep 2022 | Type: Regional

The colorectal cancer market in the Middle East & Africa is expected to grow from US$ 885.81 million in 2022 to US$ 1,076.92 million by 2028; it is estimated to grow at a CAGR of 2.5% from 2022 to 2028.

 

Numerous benefits offered by generic drugs is among the major factor driving the growth of the Middle East & Africa colorectal cancer market. Generic drugs are alternatives to branded drugs. The pharmacological effects of generic drugs are similar to their branded counterparts. Generic drugs are cost-effective as the manufacturers do not invest in developing and marketing a new drug. After the expiry of a drug patent, other manufacturers apply for FDA approval of a generic intended for its manufacturing and selling. Thus, generic drugs are cheaper than their branded counterparts. Generic drugs have the same dosage, effects and side effects, route of administration, risks, safety, and strength as the original branded drugs.

 

Generic drugs are important in oncology because some anticancer drugs are only offered as generics. Patients are likely to abandon branded prescriptions associated with their higher prices. Generic drugs for cancer treatment are profitable for manufacturers and patients due to their affordability and efficacy, especially in developing countries in the Middle East & Africa, where the paying capacity of consumers is relatively low. Thus, the preference for generic drugs among consumers and the high adoption of generic drugs for colorectal cancer treatment are fueling the growth of the colorectal cancer market in the region.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa colorectal cancer market at a substantial CAGR during the forecast period.

 

 Middle East & Africa Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)

 Middle East & Africa Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

 

 

 

Middle East & Africa Colorectal Cancer Market Segmentation

 

The Middle East & Africa colorectal cancer market is segmented into modality, end user, and country. Based on modality, the Middle East & Africa colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment held the largest market share and is expected to register the highest CAGR during the forecast period. Based on end user, the Middle East & Africa colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment held a larger market share. Based on country, the Middle East & Africa colorectal cancer market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held the largest market share in 2022.

 

Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited are among the leading companies operating in the Middle East & Africa colorectal cancer market. 

1.           Introduction  20

1.1         Scope of the Study. 20

1.2         The Insight Partners Research Report Guidance. 20

1.3         Market Segmentation. 22

1.3.1        MEA Colorectal Cancer Market – By Modality. 24

1.3.2        MEA Colorectal Cancer Market – By End User 25

1.3.3        MEA Colorectal Cancer Market – By Country. 25

2.           MEA Colorectal Cancer Market – Key Takeaways  26

3.        Research Methodology  29

3.1         Coverage. 31

3.2         Secondary Research. 31

3.3         Primary Research. 32

4.           MEA Colorectal Cancer– Market Landscape  33

4.1         Overview.. 33

4.2         MEA PEST Analysis. 34

4.3         Expert Opinion. 35

5.           MEA Colorectal Cancer Market – Key Market Dynamics  36

5.1         Market Drivers. 36

5.1.1        Increasing Prevalence of Colorectal Cancer 36

5.1.2        New Product Launches. 36

5.1.3        Benefits Offered by Generic Drugs. 37

5.2         Market Restraints. 38

5.2.1        Pricing Pressure on Drug Manufacturers. 38

5.3         Future Trends. 38

5.3.1        Inclination Toward Personalized Medicine. 38

5.4         Impact Analysis. 39

6.           MEA Colorectal Cancer Market– MEA Analysis  40

6.1         MEA Colorectal Cancer Market Revenue Forecast and Analysis. 40

7.           MEA Colorectal Cancer Market Analysis – By Modality  41

7.1         Overview.. 41

7.2         MEA Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%) 41

7.3         Diagnosis Type. 42

7.3.1        Overview.. 42

7.3.2        Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 42

7.3.3        Immunohistochemistry. 43

7.3.3.1          Overview.. 43

7.3.3.2          Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 44

7.3.4        Stool Test 45

7.3.4.1          Overview.. 45

7.3.4.2          Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 45

7.3.5        Flexible Sigmoidoscopy. 46

7.3.5.1          Overview.. 46

7.3.5.2          Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 47

7.3.6        Colonoscopy. 48

7.3.6.1          Overview.. 48

7.3.6.2          Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 48

7.3.7        CEA Test 49

7.3.7.1          Overview.. 49

7.3.7.2          CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 50

7.3.8        Other Test 51

7.3.8.1          Overview.. 51

7.3.8.2          Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 51

7.4         Therapy Type. 52

7.4.1        Overview.. 52

7.4.2        MEA Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 53

7.4.3        Chemotherapy. 54

7.4.3.1          Overview.. 54

7.4.3.2          Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 54

7.4.3.3          Alkylating Agent 55

7.4.3.3.1          Overview.. 55

7.4.3.3.2          Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 56

7.4.3.4          Antimetabolites. 57

7.4.3.4.1          Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 57

7.4.3.5          Others. 58

7.4.3.5.1          Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 59

7.4.4        Immunotherapy. 60

7.4.4.1          Overview.. 60

7.4.4.2          Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 60

7.4.4.3          Panitumumab. 61

7.4.4.3.1          Overview.. 61

7.4.4.3.2          Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 62

7.4.4.4          Cetuximab. 63

7.4.4.4.1          Overview.. 63

7.4.4.4.2          Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 63

7.4.4.5          Bevacizumab. 64

7.4.4.5.1          Overview.. 64

7.4.4.5.2          Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 65

7.4.4.6          Others. 66

7.4.4.6.1          Overview.. 66

7.4.4.6.2          Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 66

7.4.5        Chemoprotectant 67

7.4.5.1          Overview.. 67

7.4.5.2          Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 68

7.4.6        Others. 69

7.4.6.1          Overview.. 69

7.4.6.2          Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 69

7.5         Imaging Type. 70

7.5.1        Overview.. 70

7.5.2        MEA Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 71

7.5.3        Computed Tomography (CT) 72

7.5.3.1          Overview.. 72

7.5.3.2          Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 72

7.5.4        Magnetic Resonance Imaging (MRI) 73

7.5.4.1          Overview.. 73

7.5.4.2          Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 74

7.5.5        Others. 75

7.5.5.1          Overview.. 75

7.5.5.2          Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 75

8.           MEA Colorectal Cancer Market Revenue and Forecast To 2028 – By End User  77

8.1         Overview.. 77

8.2         MEA Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%) 77

8.3         Hospitals. 78

8.3.1        Overview.. 78

8.3.2        Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 78

8.4         Diagnostic and Research Laboratories. 79

8.4.1        Overview.. 79

8.4.2        Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 80

9.           MEA Colorectal Cancer Market Revenue and Forecast to 2028 – Country Analysis  81

9.1         Overview.. 81

9.1.1        MEA Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%) 83

9.1.1.1          UAE Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 83

9.1.1.1.1          UAE Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 84

9.1.1.1.2          UAE: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million) 85

9.1.1.1.2.1       UAE: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million) 86

9.1.1.1.2.2       UAE: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million) 87

9.1.1.1.2.2.1             UAE: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million) 88

9.1.1.1.2.2.2             UAE: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million) 88

9.1.1.1.2.3       UAE: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million) 89

9.1.1.1.3          UAE : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 90

9.1.1.2          Saudi Arabia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million) 91

9.1.1.2.1          Saudi Arabia Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 91

9.1.1.2.2          Saudi Arabia: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million) 92

9.1.1.2.2.1       Saudi Arabia: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million) 93

9.1.1.2.2.2       Saudi Arabia: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million) 94

9.1.1.2.2.2.1             Saudi Arabia: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million) 94

9.1.1.2.2.2.2             Saudi Arabia: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million) 95

9.1.1.2.2.3       Saudi Arabia: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million) 96

9.1.1.2.3          Saudi Arabia: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 96

9.1.1.3          South Africa Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 97

9.1.1.3.1          South Africa Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 98

9.1.1.3.2          South Africa: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million) 99

9.1.1.3.2.1       South Africa: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million) 100

9.1.1.3.2.2       South Africa: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million) 101

9.1.1.3.2.2.1             South Africa: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million) 102

9.1.1.3.2.2.2             South Africa: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million) 102

9.1.1.3.2.3       South Africa: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million) 103

9.1.1.3.3          South Africa: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 104

9.1.1.4          Rest of MEA: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million) 104

9.1.1.4.1          Overview.. 104

9.1.1.4.2          Rest of MEA: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million) 105

9.1.1.4.3          Rest of MEA: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million) 106

9.1.1.4.3.1       Rest of MEA:: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million) 107

9.1.1.4.3.2       Rest of MEA: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million) 108

9.1.1.4.3.2.1             Rest of MEA: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million) 109

9.1.1.4.3.2.2             Rest of MEA: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million) 109

9.1.1.4.3.3       Rest of MEA: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million) 110

9.1.1.4.4          Rest of MEA: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 111

10.        Colorectal Cancer Market – Industry Landscape  112

10.1      Overview.. 112

10.2      Growth Strategies In The Colorectal Cancer Market, 2022-2028. 113

10.3      Organic Developments. 114

10.3.1     Overview.. 114

10.3.2     Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028. 114

10.4      Inorganic Developments. 115

10.4.1     Overview.. 115

10.4.2     Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028. 116

11.        Company Profiles  119

11.1      Epigenomics AG.. 119

11.1.1     Key Facts. 119

11.1.2     Business Description. 119

11.1.3     Products and Services. 120

11.1.4     Financial Overview.. 120

11.1.5     SWOT Analysis. 122

11.1.6     Key Developments. 123

11.2      Abbott 124

11.2.1     Key Facts. 124

11.2.2     Business Description. 124

11.2.3     Products and Services. 125

11.2.4     Financial Overview.. 127

11.2.5     SWOT Analysis. 129

11.2.6     Key Developments. 130

11.3      Amgen Inc. 131

11.3.1     Key Facts. 131

11.3.2     Business Description. 131

11.3.3     Products and Services. 132

11.3.4     Financial Overview.. 133

11.3.5     SWOT Analysis. 135

11.3.6     Key Developments. 136

11.4      F. HOFFMANN-LA ROCHE LTD. 137

11.4.1     Key Facts. 137

11.4.2     Business Description. 137

11.4.3     Products and Services. 138

11.4.4     Financial Overview.. 139

11.4.5     SWOT Analysis. 141

11.4.6     Key Developments. 142

11.5      Bruker Corporation. 143

11.5.1     Key Facts. 143

11.5.2     Business Description. 143

11.5.3     Products and Services. 144

11.5.4     Financial Overview.. 144

11.5.5     SWOT Analysis. 147

11.5.6     Key Developments. 148

11.6      Quest Diagnostics Incorporated. 149

11.6.1     Key Facts. 149

11.6.2     Business Description. 149

11.6.3     Products and Services. 150

11.6.4     Financial Overview.. 150

11.6.5     SWOT Analysis. 152

11.6.6     Key Developments. 153

11.7      Volitionrx Limited. 154

11.7.1     Key Facts. 154

11.7.2     Business Description. 154

11.7.3     Products and Services. 155

11.7.4     Financial Overview.. 155

11.7.5     SWOT Analysis. 157

11.7.6     Key Developments. 158

12.        Appendix  159

12.1      About The Insight Partners. 159

12.2      Glossary of Terms. 159

 

 

 

LIST OF TABLES

Table 1.             UAE Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million) 85

Table 2.             UAE Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million) 86

Table 3.             UAE Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million) 87

Table 4.             UAE Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million) 88

Table 5.             UAE Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million) 88

Table 6.             UAE Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million) 89

Table 7.             UAE: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 90

Table 8.             Saudi Arabia Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million) 92

Table 9.             Saudi Arabia Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million) 93

Table 10.          Saudi Arabia Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million) 94

Table 11.          Saudi Arabia Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million) 94

Table 12.          Saudi Arabia Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million) 95

Table 13.          Saudi Arabia Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million) 96

Table 14.          Saudi Arabia: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 96

Table 15.          South Africa Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million) 99

Table 16.          South Africa Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million) 100

Table 17.          South Africa Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million) 101

Table 18.          South Africa Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million) 102

Table 19.          South Africa Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million) 102

Table 20.          South Africa Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million) 103

Table 21.          South Africa: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million) 104

Table 22.          Rest of MEA: Colorectal Cancer Market Revenue and Forecasts To 2028, By Modality (US$ Million) 106

Table 23.          Rest of MEA: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million) 107

Table 24.          Rest of MEA: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million) 108

Table 25.          Rest of MEA: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million) 109

Table 26.          Rest of MEA: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million) 109

Table 27.          Rest of MEA: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million) 110

Table 28.          Rest of MEA: Colorectal Cancer Market Revenue and Forecasts To 2028, By End User (US$ Million) 111

Table 29.          Recent Organic Growth Strategies In The Colorectal Cancer Market 114

Table 30.          Recent Inorganic Growth Strategies In The Colorectal Cancer Market 116

Table 31.          Glossary of Terms, MEA Colorectal Cancer Market 159

 

 

LIST OF FIGURES

Figure 1.           MEA Colorectal Cancer Market Segmentation. 22

Figure 2.           MEA Colorectal Cancer Segmentation, By Country. 23

Figure 3.           MEA Colorectal Cancer Market Overview.. 26

Figure 4.           Diagnosis Type Segment Held Largest Share Of Modality Segment In MEA Colorectal Cancer Market 27

Figure 5.           UAE is Expected To Show Remarkable Growth During The Forecast Period. 28

Figure 6.           MEA Colorectal Cancer Market – PEST Analysis. 34

Figure 7.           Comparison of Branded Drugs and Generic Drugs. 37

Figure 8.           MEA Colorectal Cancer Market Impact Analysis of Drivers And Restraints. 39

Figure 9.           MEA Colorectal Cancer Market – Revenue Forecasts And Analysis – 2020- 2028. 40

Figure 10.        MEA Colorectal Cancer Market Revenue Share, by Modality 2022 & 2028 (%) 41

Figure 11.        MEA Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 43

Figure 12.        MEA Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 44

Figure 13.        MEA Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 46

Figure 14.        MEA Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 47

Figure 15.        MEA Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 49

Figure 16.        MEA CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 50

Figure 17.        MEA Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 52

Figure 18.        MEA Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 53

Figure 19.        MEA Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 55

Figure 20.        Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 56

Figure 21.        MEA Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 58

Figure 22.        MEA Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 59

Figure 23.        MEA Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 61

Figure 24.        MEA Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 62

Figure 25.        MEA Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 64

Figure 26.        MEA Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 65

Figure 27.        MEA Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 67

Figure 28.        MEA Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 68

Figure 29.        MEA Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 70

Figure 30.        MEA Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 71

Figure 31.        Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 73

Figure 32.        MEA Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 74

Figure 33.        MEA Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 76

Figure 34.        MEA Colorectal Cancer Market Revenue Share, by End User 2022 & 2028 (%) 77

Figure 35.        MEA Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 79

Figure 36.        MEA Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million) 80

Figure 37.        MEA: Colorectal Cancer Market Revenue Overview, By Key Country – Revenue (2022) (US$ Million) 82

Figure 38.        MEA Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%) 83

Figure 39.        UAE Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million) 84

Figure 40.        Saudi Arabia Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 92

Figure 41.        South Africa Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million) 98

Figure 42.        Rest of MEA: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million) 105

Figure 43.        Growth Strategies In The Colorectal Cancer Market, 2022-2028. 113

 

  1. Abbott
  2. Amgen Inc.
  3. Bruker Corporation
  4. Epigenomics AG
  5. F. Hoffmann-La Roche AG
  6. Quest Diagnostics  
  7. VolitionRx Limited
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000